Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer

BACKGROUND: The mTOR signaling pathway plays an important role in cancer. As a master regulator, the status of MTOR affects pathway activity and the efficacy of mTOR inhibitor therapy. However, little research has been performed to explore MTOR in colorectal cancer (CRC). METHODS: In this study, gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chenxing, Aikemu, Batuer, Shao, Yanfei, Zhang, Sen, Yang, Guang, Hong, Hiju, Huang, Ling, Jia, Hongtao, Yang, Xiao, Zheng, Minhua, Sun, Jing, Li, Jianwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327395/
https://www.ncbi.nlm.nih.gov/pubmed/35883111
http://dx.doi.org/10.1186/s12885-022-09901-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327395/
https://www.ncbi.nlm.nih.gov/pubmed/35883111
http://dx.doi.org/10.1186/s12885-022-09901-w

Ejemplares similares